Among patients with type-2 diabetes (T2D) requiring insulin therapy, automated insulin delivery (AID) resulted in a greater ...

Diabetes treatment has advanced since several diabetes organizations united to recommend a “time in range” target of 70-180 mg/dL for glucose levels derived from continuous glucose monitoring ...